ALK

CEP-28122 is a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.

ALK inhibitor 1 is a novel and selective inhibitor for the ALK kinase.

R-268712 is a potent and selective inhibitor of ALK5 with an IC50 of 2.5 nM.

HG-14-10-04 is a potent and specific ALK inhibitor with IC50 of 20 nM.

SM 16 is a ALK5/ALK4 kinase inhibitor with Kis of 10 and 1.5 nM, respectively.

MS4078 is an anaplastic lymphoma kinase (ALK) PROTAC (degrader) with a Kd of 19?nM for binding affinity to ALK.